Benefits of a contralateral routing of signal device for unilateral Naída CI cochlear implant recipients.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 08 01 2019
accepted: 08 05 2019
pubmed: 19 5 2019
medline: 19 11 2019
entrez: 19 5 2019
Statut: ppublish

Résumé

Many bilaterally deaf adults are only able to receive one cochlear implant (CI), resulting in suboptimal listening performance, especially in challenging listening environments. Adding a contralateral routing of signal (CROS) device to a unilateral CI is one possibility to alleviate these challenges. This study examined the benefit of such a CROS device. Thirteen adult subjects with at least 6 months of CI use, and no or limited benefit of a hearing instrument in the contralateral ear were included in the study. The perceived benefit of a CROS device in everyday listening environments was evaluated up to 1 year after initial fitting using several questionnaires. Speech intelligibility performance was determined using the French matrix sentence test in quiet and in two speech-in-noise setups and was followed for 3 months after CROS fitting. Subjects indicated high satisfaction with the practical usability of the CROS device and long-term device retention was high. Perceived benefits in everyday listening environments were reported. Formal speech intelligibility tests revealed statistically significant median improvements of 6.93 dB SPL (Wilcoxon Z = 2.380, p = 0.017) in quiet and up to 8.00 dB SNR (Wilcoxon Z = 2.366, p = 0.018) in noise. These benefits were accessible immediately without a need for prolonged acclimatization. Subjective satisfaction and device retention as well as speech intelligibility benefits in quiet and in noise prove the CROS device to be a valuable addition to a unilateral CI in cases of bilateral deafness where bilateral implantation is not an option.

Identifiants

pubmed: 31102018
doi: 10.1007/s00405-019-05467-9
pii: 10.1007/s00405-019-05467-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2205-2213

Références

Clin Otolaryngol. 2012 Oct;37(5):342-54
pubmed: 22928754
Clin Otolaryngol. 2015 Dec;40(6):535-44
pubmed: 25715980
Int J Audiol. 2012 Mar;51(3):164-73
pubmed: 22122354
Otol Neurotol. 2009 Apr;30(3):313-8
pubmed: 19318885
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2213-9
pubmed: 24952106
J Am Acad Audiol. 2019 Mar;30(3):235-242
pubmed: 30461413
Audiol Neurootol. 2016;21(4):261-267
pubmed: 27653609
Laryngoscope. 2013 Mar;123(3):746-51
pubmed: 23404529
Int J Audiol. 2004 Feb;43(2):85-99
pubmed: 15035561
JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):249-56
pubmed: 26796630
J Am Acad Audiol. 2019 Jul/Aug;30(7):579-589
pubmed: 30541657
Otol Neurotol. 2013 Feb;34(2):190-8
pubmed: 23444466
Otol Neurotol. 2014 Oct;35(9):e233-9
pubmed: 25226266
Audiol Neurootol. 2015;20(2):73-80
pubmed: 25501444
Cochlear Implants Int. 2019 Jul;20(4):182-189
pubmed: 30821202
Ear Hear. 1995 Apr;16(2):176-86
pubmed: 7789669
Laryngoscope. 2015 Jan;125(1):197-202
pubmed: 25224587
J Acoust Soc Am. 2016 Jul;140(1):393
pubmed: 27475163
Ear Hear. 2017 May/Jun;38(3):368-373
pubmed: 28166088
Laryngoscope. 2014 Jun;124(6):1452-8
pubmed: 24431194
Audiol Neurootol. 2009;14(2):106-14
pubmed: 18832816
Int J Audiol. 2013 Jun;52(6):409-12
pubmed: 23651462

Auteurs

Isabelle Mosnier (I)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France. isabelle.mosnier@aphp.fr.
AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France. isabelle.mosnier@aphp.fr.
Unité Otologie, Implants auditifs et Chirurgie de la base du crâne, GH Pitié-Salpêtrière-Bâtiment Castaigne, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. isabelle.mosnier@aphp.fr.

Ghizlene Lahlou (G)

AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France.
Sorbonne Université, Institut Pasteur, Inserm, Unité de génétique et de physiologie de l'Audition, Paris, France.

Jonathan Flament (J)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France.
Laboratoire Audika, Paris, France.

Nathalie Mathias (N)

Advanced Bionics, Bron, France.

Evelyne Ferrary (E)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France.
AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France.

Olivier Sterkers (O)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France.
AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France.

Daniele Bernardeschi (D)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France.
AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France.

Yann Nguyen (Y)

Sorbonne Université, Inserm, Unité de Réhabilitation chirurgicale mini-invasive robotisée de l'audition, Paris, France.
AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants auditifs et chirurgie de la base du crâne, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH